Charlie is the co-founder of Adjuvant Capital, which manages a $300m venture capital fund focused on life sciences technologies for high-burden public health challenges. Previously, he was with the Global Health Investment Fund, an experimental investment vehicle formed by JP Morgan and the Bill & Melinda Gates Foundation. Prior to his career investing in global health research and development, he was a private equity investor at Artemis.